These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17457717)

  • 1. The workings of the amyloid diseases.
    Bellotti V; Nuvolone M; Giorgetti S; Obici L; Palladini G; Russo P; Lavatelli F; Perfetti V; Merlini G
    Ann Med; 2007; 39(3):200-7. PubMed ID: 17457717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V; Mangione P; Merlini G
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G; Verine J; Delpech M; Ries M
    Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
    Booth DR; Sunde M; Bellotti V; Robinson CV; Hutchinson WL; Fraser PE; Hawkins PN; Dobson CM; Radford SE; Blake CC; Pepys MB
    Nature; 1997 Feb; 385(6619):787-93. PubMed ID: 9039909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene.
    Röcken C; Becker K; Fändrich M; Schroeckh V; Stix B; Rath T; Kähne T; Dierkes J; Roessner A; Albert FW
    Hum Mutat; 2006 Jan; 27(1):119-20. PubMed ID: 16329101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analysis of the S. cerevisiae proteome reveals the function and cellular localization of the least and most amyloidogenic proteins.
    Tartaglia GG; Caflisch A
    Proteins; 2007 Jul; 68(1):273-8. PubMed ID: 17407164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein aggregation and deposition: implications for ion channel formation and membrane damage.
    Kourie JI; Henry CL
    Croat Med J; 2001 Aug; 42(4):359-74. PubMed ID: 11471187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
    Glabe CG
    Neurobiol Aging; 2006 Apr; 27(4):570-5. PubMed ID: 16481071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis.
    Sipe JD
    Crit Rev Clin Lab Sci; 1994; 31(4):325-54. PubMed ID: 7888076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the mechanism of formation of native-like and precursor amyloid oligomers for the native acylphosphatase from Sulfolobus solfataricus.
    Plakoutsi G; Bemporad F; Monti M; Pagnozzi D; Pucci P; Chiti F
    Structure; 2006 Jun; 14(6):993-1001. PubMed ID: 16765892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural models of amyloid-like fibrils.
    Nelson R; Eisenberg D
    Adv Protein Chem; 2006; 73():235-82. PubMed ID: 17190616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloidosis-associated kidney disease.
    Dember LM
    J Am Soc Nephrol; 2006 Dec; 17(12):3458-71. PubMed ID: 17093068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, function and amyloidogenic propensity of apolipoprotein A-I.
    Obici L; Franceschini G; Calabresi L; Giorgetti S; Stoppini M; Merlini G; Bellotti V
    Amyloid; 2006 Dec; 13(4):191-205. PubMed ID: 17107880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal amyloidosis (part I).
    Ferrario F; Rastaldi MP
    J Nephrol; 2006; 19(2):123-5. PubMed ID: 16736407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures for amyloid fibrils.
    Makin OS; Serpell LC
    FEBS J; 2005 Dec; 272(23):5950-61. PubMed ID: 16302960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation stimulates amyloid formation.
    Obrenovich ME; Monnier VM
    Sci Aging Knowledge Environ; 2004 Jan; 2004(2):pe3. PubMed ID: 14724325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding proteins in fatal ways.
    Selkoe DJ
    Nature; 2003 Dec; 426(6968):900-4. PubMed ID: 14685251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.